Prostaglandin F2alpha
Overview of Prostaglandin F2alpha
| Prostaglandin F2alpha | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | Intramuscular, Intrauterine |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | 551-11-1 |
| PubChem | 5280360 |
| DrugBank | DB01160 |
| ChemSpider | 4445530 |
| KEGG | D00074 |
Prostaglandin F2α (PGF2α) is a naturally occurring prostaglandin used in medicine to induce labor and as a treatment for postpartum hemorrhage. It is also used in veterinary medicine to synchronize estrus in livestock.
Biological Role
Prostaglandin F2α is a member of the prostaglandin family, which are lipid compounds derived from fatty acids. PGF2α plays a crucial role in the reproductive system, particularly in the regulation of the estrous cycle and the induction of parturition. It is synthesized in the endometrium and acts on the corpus luteum to induce luteolysis, leading to a decrease in progesterone production and the initiation of a new estrous cycle.
Medical Uses
In human medicine, PGF2α is used to induce labor and control postpartum hemorrhage due to its ability to stimulate uterine contractions. It is administered via intramuscular or intrauterine routes. PGF2α is also used in the management of glaucoma as it can reduce intraocular pressure.
In veterinary medicine, PGF2α is used to synchronize estrus in cattle, swine, and other livestock. This is achieved by inducing luteolysis, which allows for controlled breeding programs.
Mechanism of Action
Prostaglandin F2α exerts its effects by binding to specific prostaglandin receptors on the surface of target cells. This binding activates intracellular signaling pathways that lead to increased intracellular calcium levels, resulting in muscle contraction. In the uterus, this causes the myometrium to contract, facilitating labor or expulsion of the placenta.
Side Effects
The use of PGF2α can lead to side effects such as nausea, vomiting, diarrhea, and fever. In some cases, it may cause bronchospasm, particularly in patients with a history of asthma.
Also see
References
- Smith, W. L., & Marnett, L. J. (1991). Prostaglandin endoperoxide synthase: structure and catalysis. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1083(1), 1-17.
- Fortier, M. A., Guilbault, L. A., & Grasso, F. (1988). Specific properties of epithelial and stromal cells from the endometrium of cows. Journal of Reproduction and Fertility, 83(1), 239-248.
Template:Reproductive system drugs Template:Veterinary drugs
Ad. Transform your life with W8MD's
GLP-1 weight loss injections special from $29.99 with insurance
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian